Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 16;10(3):656.
doi: 10.3390/cells10030656.

Mechanisms of Neurodegeneration in Various Forms of Parkinsonism-Similarities and Differences

Dariusz Koziorowski  1 , Monika Figura  1 , Łukasz M Milanowski  1   2   3 , Stanisław Szlufik  1 , Piotr Alster  1 , Natalia Madetko  1 , Andrzej Friedman  1
Affiliations
Review

Mechanisms of Neurodegeneration in Various Forms of Parkinsonism-Similarities and Differences

Dariusz Koziorowski et al. Cells. .

Abstract

Parkinson's disease (PD), dementia with Lewy body (DLB), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA) belong to a group of neurodegenerative diseases called parkinsonian syndromes. They share several clinical, neuropathological and genetic features. Neurodegenerative diseases are characterized by the progressive dysfunction of specific populations of neurons, determining clinical presentation. Neuronal loss is associated with extra- and intracellular accumulation of misfolded proteins. The parkinsonian diseases affect distinct areas of the brain. PD and MSA belong to a group of synucleinopathies that are characterized by the presence of fibrillary aggregates of α-synuclein protein in the cytoplasm of selected populations of neurons and glial cells. PSP is a tauopathy associated with the pathological aggregation of the microtubule associated tau protein. Although PD is common in the world's aging population and has been extensively studied, the exact mechanisms of the neurodegeneration are still not fully understood. Growing evidence indicates that parkinsonian disorders to some extent share a genetic background, with two key components identified so far: the microtubule associated tau protein gene (MAPT) and the α-synuclein gene (SNCA). The main pathways of parkinsonian neurodegeneration described in the literature are the protein and mitochondrial pathways. The factors that lead to neurodegeneration are primarily environmental toxins, inflammatory factors, oxidative stress and traumatic brain injury.

Keywords: DLB; MAPT; MSA; PD; PSP; SNCA; mitophagy; neurodegeneration; oxidative stress.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Coexistence of different mechanisms of neurodegeneration in parkinsonism. PD—Parkinson’s disease; CBD—corticobasal degeneration; PSP—progressive supranuclear palsy; MSA—multiple system atrophy; DLB—dementia with Lewy bodies.
Figure 2
Figure 2
Mechanisms of toxin-induced neurodegeneration.
See this image and copyright information in PMC

References

    1. Postuma R.B., Berg D., Stern M., Poewe W., Olanow C.W., Oertel W., Obeso J., Marek K., Litvan I., Lang A.E. MDS clinical diagnostic criteria for Parkinson’s disease. Mov. Disord. 2015;30:1591–1601. doi: 10.1002/mds.26424. - DOI - PubMed
    1. Gilman S., Wenning G.K., A Low P., Brooks D.J., Mathias C.J., Trojanowski J.Q., Wood N.W., Colosimo C., Durr A., Fowler C.J., et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71:670–676. doi: 10.1212/01.wnl.0000324625.00404.15. - DOI - PMC - PubMed
    1. Höglinger G.U., Respondek G., Stamelou M., Kurz C., Josephs K.A., Lang A.E., Mollenhauer B., Müller U., Nilsson C., Whitwell J.L., et al. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov. Disord. 2017;32:853–864. doi: 10.1002/mds.26987. - DOI - PMC - PubMed
    1. Armstrong M.J., Litvan I., Lang A.E., Bak T.H., Bhatia K.P., Borroni B., Boxer A.L., Dickson D.W., Grossman M., Hallett M., et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80:496–503. doi: 10.1212/WNL.0b013e31827f0fd1. - DOI - PMC - PubMed
    1. Yamada M., Komatsu J., Nakamura K., Sakai K., Samuraki-Yokohama M., Nakajima K., Yoshita M. Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions. J. Mov. Disord. 2020;13:1–10. doi: 10.14802/jmd.19052. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources